BioSpace News Archive

BioLineRx Ltd., a late clinical-stage biopharmaceutical company focused on oncology, announced that a sufficient number of patients have been enrolled in the ongoing GENESIS Phase 3 trial to allow for an interim efficacy analysis to take place in the second half of 2020.

In hematology oncology, it is critically important to understand the genetics driving acute malignancies to quickly determine how best to address the disease.

The number of Americans afflicted with Lyme disease was found to be 10 times greater than the 30,000 cases reported each year to the Centers for Disease Control and Prevention, according to a groundbreaking seven-year clinical study just released.

Phase 1/2 “INTREPID” trial to evaluate safety and ability of engineered FGF-1 to regenerate corneal endothelial cells

Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT®, its non-invasive and flexible continuous glucose monitor (“CGM”), together with BEAT™diabetes, a planned health subscription service designed to help people with Type 2 diabetes and prediabetes through personaliz

Critical research led by Sunnybrook Health Sciences Centre into suicide prevention during the COVID-19 pandemic is receiving an immediate $100,000 donation from TELUS President and CEO Darren Entwistle and the Entwistle Family Foundation.

Daré Bioscience, Inc., a leader in women’s health innovation, announced that it received a Notice of Award of a grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, a division of the National Institutes of Health.

rMark Bio, a leader in the application of AI to accelerate innovation, collaboration, and scientific discovery for the life sciences industry, today announced the formation of its new Advisory Board.

Health Care Compliance Association (HCCA) is transitioning the Clinical Practice Compliance Conference and the Healthcare Enforcement Compliance Conference to online, interactive conferences this fall.

Intellicure, a pioneering wound care electronic health record (EHR) company, has announced a partnership with Smith+Nephew, to allow for in–chart ordering of its RENASYS GO system using Intellicure’s durable medical equipment (DME) tool called OrderTrak.